143 related articles for article (PubMed ID: 36813250)
1. The prevalence of SARS-CoV-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June-July 2022.
Qasmieh SA; Robertson MM; Teasdale CA; Kulkarni SG; Jones HE; McNairy M; Borrell LN; Nash D
Prev Med; 2023 Apr; 169():107461. PubMed ID: 36813250
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of SARS-CoV-2 infection and other public health outcomes during the BA.2/BA.2.12.1 surge, New York City, April-May 2022.
Qasmieh SA; Robertson MM; Teasdale CA; Kulkarni SG; Jones HE; Larsen DA; Dennehy JJ; McNairy M; Borrell LN; Nash D
Commun Med (Lond); 2023 Jun; 3(1):92. PubMed ID: 37391483
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Infection and Testing Experiences in a Nationwide Sample of Transgender and Gender-Diverse Adults, June-December 2021.
Wirtz AL; Adams D; Poteat TC; Beckham SW; Miller M; Brown C; Reisner SL
Public Health Rep; 2023; 138(2):357-368. PubMed ID: 36560869
[TBL] [Abstract][Full Text] [Related]
4. The Epidemiology of Long Coronavirus Disease in US Adults.
Robertson MM; Qasmieh SA; Kulkarni SG; Teasdale CA; Jones HE; McNairy M; Borrell LN; Nash D
Clin Infect Dis; 2023 May; 76(9):1636-1645. PubMed ID: 36542514
[TBL] [Abstract][Full Text] [Related]
5. Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.
Khan FL; Nguyen JL; Singh TG; Puzniak LA; Wiemken TL; Schrecker JP; Taitel MS; Zamparo JM; Jodar L; McLaughlin JM
JAMA Netw Open; 2022 Dec; 5(12):e2246915. PubMed ID: 36515946
[TBL] [Abstract][Full Text] [Related]
6. Estimating the Period Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During the Omicron (BA.1) Surge in New York City (NYC), 1 January to 16 March 2022.
Qasmieh SA; Robertson MM; Teasdale CA; Kulkarni SG; Nash D
Clin Infect Dis; 2023 Feb; 76(3):e499-e502. PubMed ID: 35959571
[TBL] [Abstract][Full Text] [Related]
7. Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics.
Hirschtick JL; Titus AR; Slocum E; Power LE; Hirschtick RE; Elliott MR; McKane P; Fleischer NL
Clin Infect Dis; 2021 Dec; 73(11):2055-2064. PubMed ID: 34007978
[TBL] [Abstract][Full Text] [Related]
8. Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS-CoV-2 Omicron wave: a cross-sectional survey.
Woldegiorgis M; Cadby G; Ngeh S; Korda RJ; Armstrong PK; Maticevic J; Knight P; Jardine A; Bloomfield LE; Effler PV
Med J Aust; 2024 Apr; 220(6):323-330. PubMed ID: 38508863
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and predictors of perceived COVID-19 stigma within a population-based sample of adults with COVID-19.
Ryu S; Chaubal S; Guro P; King EJ; Orellana R; Fleischer NL; Hirschtick JL
BMC Public Health; 2023 Oct; 23(1):2110. PubMed ID: 37891499
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
[TBL] [Abstract][Full Text] [Related]
11. Acute and Post-Acute COVID-19 Outcomes Among Immunologically Naïve Adults During Delta Versus Omicron Waves.
Doll MK; Waghmare A; Heit A; Levenson Shakoor B; Kimball LE; Ozbek N; Blazevic RL; Mose L; Boonyaratanakornkit J; Stevens-Ayers TL; Cornell K; Sheppard BD; Hampson E; Sharmin F; Goodwin B; Dan JM; Archie T; O'Connor T; Heckerman D; Schmitz F; Boeckh M; Crotty S
medRxiv; 2022 Nov; ():. PubMed ID: 36425923
[TBL] [Abstract][Full Text] [Related]
12. Disparities and Temporal Trends in COVID-19 Exposures and Mitigating Behaviors Among Black and Hispanic Adults in an Urban Setting.
Badri S; Sardá V; Moncada JS; Merçon M; Rezai K; Weinstein RA; Trick WE
JAMA Netw Open; 2021 Sep; 4(9):e2125187. PubMed ID: 34581798
[TBL] [Abstract][Full Text] [Related]
13. The health impact of long COVID during the 2021-2022 Omicron wave in Australia: a quantitative burden of disease study.
Howe S; Szanyi J; Blakely T
Int J Epidemiol; 2023 Jun; 52(3):677-689. PubMed ID: 37011639
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
15. The Importance of Incorporating At-Home Testing Into SARS-CoV-2 Point Prevalence Estimates: Findings From a US National Cohort, February 2022.
Qasmieh SA; Robertson MM; Rane MS; Shen Y; Zimba R; Picchio CA; Parcesepe AM; Chang M; Kulkarni SG; Grov C; Nash D
JMIR Public Health Surveill; 2022 Dec; 8(12):e38196. PubMed ID: 36240020
[TBL] [Abstract][Full Text] [Related]
16. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Correlates of Long COVID Symptoms Among US Adults.
Perlis RH; Santillana M; Ognyanova K; Safarpour A; Lunz Trujillo K; Simonson MD; Green J; Quintana A; Druckman J; Baum MA; Lazer D
JAMA Netw Open; 2022 Oct; 5(10):e2238804. PubMed ID: 36301542
[TBL] [Abstract][Full Text] [Related]
19. Importance of occupation for SARS-CoV-2 seroprevalence and COVID-19 vaccination among correctional workers in Quebec, Canada: A cross-sectional study.
Kronfli N; Dussault C; Maheu-Giroux M; Halavrezos A; Chalifoux S; Park H; Balso LD; Cheng MP; Cox J
Front Public Health; 2022; 10():1021871. PubMed ID: 36438247
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
